IL-12Rβ2 is essential for the development of experimental cerebral malaria

Journal of Immunology

Volumn 188, Issue 4, 2012, Pages 1905-1914

  Fauconnier, Mathilde ^a,b   Palomo, Jennifer ^a,b   Bourigault, Marie Laure ^a,b   Meme, Sandra ^c   Szeremeta, Frédéric ^c   Beloeil, Jean Claude ^c   Danneels, Adeline ^a,b   Charron, Sabine ^a,b   Rihet, Pascal ^d,e   Ryffel, Bernhard ^a,b,f   Quesniaux, Valérie F J ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^d Aix Marseille university   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f Institute of Infectious Disease and Molecular Medicine   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P35; INTERLEUKIN 12P40; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN MALARIA; BRAIN MICROCIRCULATION; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE RESISTANCE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MOUSE; NEUROPATHOLOGY; NON INVASIVE PROCEDURE; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WILD TYPE;

ANIMALS; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; INTERFERON-GAMMA; INTERLEUKIN-12 RECEPTOR BETA 2 SUBUNIT; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; LYMPHOCYTE ACTIVATION; LYMPHOTOXIN-ALPHA; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMODIUM BERGHEI; SIGNAL TRANSDUCTION; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856884680     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101978     Document Type: Article

References (51)

1. Belnoue, E., M. Kayibanda, A. M. Vigario, J. C. Deschemin, N. van Rooijen, M. Viguier, G. Snounou, and L. Rénia. 2002. On the pathogenic role of brainsequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 169: 6369-6375. (Pubitemid 36903485)
2. Schofield, L., and G. E. Grau. 2005. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5: 722-735. (Pubitemid 43086173)
3. Rénia, L., S. M. Potter, M. Mauduit, D. S. Rosa, M. Kayibanda, J. C. Deschemin, G. Snounou, and A. C. Grüner. 2006. Pathogenic T cells in cerebral malaria. Int. J. Parasitol. 36: 547-554.
4. Hunt, N. H., and G. E. Grau. 2003. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24: 491-499. (Pubitemid 37088152)
5. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91: 10700-10702. (Pubitemid 24329066)
6. Marquet, S., O. Doumbo, S. Cabantous, B. Poudiougou, L. Argiro, I. Safeukui, S. Konate, S. Sissoko, E. Chevereau, A. Traore, et al. 2008. A functional promoter variant in IL12B predisposes to cerebral malaria. Hum. Mol. Genet. 17: 2190-2195. (Pubitemid 351911987)
7. Nitcheu, J., O. Bonduelle, C. Combadiere, M. Tefit, D. Seilhean, D. Mazier, and B. Combadiere. 2003. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170: 2221-2228. (Pubitemid 36197447)
8. Suidan, G. L., J. R. Mcdole, Y. Chen, I. Pirko, and A. J. Johnson. 2008. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One 3: e3037.
9. Chang, W. L., S. P. Jones, D. J. Lefer, T. Welbourne, G. Sun, L. Yin, H. Suzuki, J. Huang, D. N. Granger, and H. C. van der Heyde. 2001. CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect. Immun. 69: 7341-7348. (Pubitemid 33086557)
10. Fauconnier, M., M. L. Bourigault, S. Meme, F. Szeremeta, J. Palomo, A. Danneels, S. Charron, L. Fick, M. Jacobs, J. C. Beloeil, et al. 2011. Protein kinase C-theta is required for development of experimental cerebral malaria. Am. J. Pathol. 178: 212-221.
11. Stevenson, M. M., M. F. Tam, S. F. Wolf, and A. Sher. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155: 2545-2556.
12. Su, Z., and M. M. Stevenson. 2002. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168: 1348-1355. (Pubitemid 34094505)
13. Adachi, K., H. Tsutsui, S. Kashiwamura, E. Seki, H. Nakano, O. Takeuchi, K. Takeda, K. Okumura, L. Van Kaer, H. Okamura, et al. 2001. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/ myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167: 5928-5934. (Pubitemid 33062788)
14. Normaznah, Y., A. A. Halim, M. Outhayphone, and M. R. Zamri. 1999. Protective immunity against Plasmodium berghei malaria after administration of interleukin-12. Malays. J. Pathol. 21: 123-125.
15. Xu, X., K. Sumita, C. Feng, X. Xiong, H. Shen, S. Maruyama, M. Kanoh, and Y. Asano. 2001. Down-regulation of IL-12 p40 gene in Plasmodium berghei-infected mice. J. Immunol. 167: 235-241. (Pubitemid 32567783)
16. Wu, C., X. Wang, M. Gadina, J. J. O'Shea, D. H. Presky, and J. Magram. 2000. IL-12 receptor beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12- mediated signaling despite the presence of high affinity IL-12 binding sites. J. Immunol. 165: 6221-6228.
17. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL- 12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4: 471-481. (Pubitemid 26354656)
18. Chen, Z., R. S. Duan, H. C. Q, Q. Wu, E. Mix, B. Winblad, H. G. Ljunggren, and J. Zhu. 2004. IL-12p35 deficiency alleviates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice. Neurobiol. Dis. 17: 171-178. (Pubitemid 39345773)
19. Franke-Fayard, B., H. Trueman, J. Ramesar, J. Mendoza, M. van der Keur, R. van der Linden, R. E. Sinden, A. P. Waters, and C. J. Janse. 2004. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol. Biochem. Parasitol. 137: 23-33. (Pubitemid 38987939)
20. Rudin, W., H. P. Eugster, G. Bordmann, J. Bonato, M. Müller, M. Yamage, and B. Ryffel. 1997. Resistance to cerebral malaria in tumor necrosis factor-alpha/ beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am. J. Pathol. 150: 257-266. (Pubitemid 27027115)
21. Togbe, D., P. L. de Sousa, M. Fauconnier, V. Boissay, L. Fick, S. Scheu, K. Pfeffer, R. Menard, G. E. Grau, B. T. Doan, et al. 2008. Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS One 3: e2608.
22. Patankar, T. F., D. R. Karnad, P. G. Shetty, A. P. Desai, and S. R. Prasad. 2002. Adult cerebral malaria: prognostic importance of imaging findings and correlation with postmortem findings. Radiology 224: 811-816. (Pubitemid 34919818)
23. Kampfl, A. W., G. G. Birbamer, B. E. Pfausler, H. P. Haring, and E. Schmutzhard. 1993. Isolated pontine lesion in algid cerebral malaria: clinical features, management, and magnetic resonance imaging findings. Am. J. Trop. Med. Hyg. 48: 818-822. (Pubitemid 23238463)
24. Looareesuwan, S., P. Wilairatana, S. Krishna, B. Kendall, S. Vannaphan, C. Viravan, and N. J. White. 1995. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin. Infect. Dis. 21: 300-309.
25. Cordoliani, Y. S., J. L. Sarrazin, D. Felten, E. Caumes, C. Lévêque, and A. Fisch.1998. MR of cerebral malaria. AJNR Am. J. Neuroradiol. 19: 871-874. (Pubitemid 30415769)
26. Penet, M. F., A. Viola, S. Confort-Gouny, Y. Le Fur, G. Duhamel, F. Kober, D. Ibarrola, M. Izquierdo, N. Coltel, B. Gharib, et al. 2005. Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J. Neurosci. 25: 7352-7358. (Pubitemid 41129807)
27. Stoelcker, B., T. Hehlgans, K. Weigl, H. Bluethmann, G. E. Grau, and D. N. Männel. 2002. Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria. Infect. Immun. 70: 5857-5859.
28. Engwerda, C. R., T. L. Mynott, S. Sawhney, J. B. De Souza, Q. D. Bickle, and P. M. Kaye. 2002. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195: 1371-1377. (Pubitemid 34564338)
29. Favre, N., C. Da Laperousaz, B. Ryffel, N. A. Weiss, B. A. Imhof, W. Rudin, R. Lucas, and P. F. Piguet. 1999. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1: 961-968.
30. Grau, G. E., P. F. Piguet, D. Gretener, C. Vesin, and P. H. Lambert. 1988. Immunopathology of thrombocytopenia in experimental malaria. Immunology 65: 501-506. (Pubitemid 19031201)
31. Barbier, M., A. Atkinson, F. Fumoux, and P. Rihet. 2008. IL12B polymorphisms are linked but not associated with Plasmodium falciparum parasitemia: a familial study in Burkina Faso. Genes Immun. 9: 405-411.
32. Morahan, G., C. S. Boutlis, D. Huang, A. Pain, J. R. Saunders, M. R. Hobbs, D. L. Granger, J. B. Weinberg, N. Peshu, E. D. Mwaikambo, et al. 2002. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun. 3: 414-418. (Pubitemid 41656540)
33. Zhang, L., D. Prather, J. Vanden Eng, S. Crawford, S. Kariuki, F. ter Kuile, D. Terlouw, B. Nahlen, A. A. Lal, L. Slutsker, et al. 2010. Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya. Malar. J. 9: 87.
34. Goriely, S., M. F. Neurath, and M. Goldman. 2008. How microorganisms tip the balance between interleukin-12 family members. Nat. Rev. Immunol. 8: 81-86.
35. Cabantous, S., B. Poudiougou, A. Traore, M. Keita, M. B. Cisse, O. Doumbo, A. J. Dessein, and S. Marquet. 2005. Evidence that interferon-gamma plays a protective role during cerebral malaria. J. Infect. Dis. 192: 854-860. (Pubitemid 41193083)
36. Stevenson, M. M., Z. Su, H. Sam, and K. Mohan. 2001. Modulation of host responses to blood-stage malaria by interleukin-12: from therapy to adjuvant activity. Microbes Infect. 3: 49-59. (Pubitemid 32172040)
37. Amani, V., A. M. Vigário, E. Belnoue, M. Marussig, L. Fonseca, D. Mazier, and L. Rénia. 2000. Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30: 1646-1655. (Pubitemid 30342807)
38. Lovegrove, F. E., S. A. Gharib, L. Peña-Castillo, S. N. Patel, J. T. Ruzinski, T. R. Hughes, W. C. Liles, and K. C. Kain. 2008. Parasite burden and CD36- mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog. 4: e1000068.
39. Epiphanio, S., M. G. Campos, A. Pamplona, D. Carapau, A. C. Pena, R. Ataíde, C. A. Monteiro, N. Félix, A. Costa-Silva, C. R. Marinho, et al. 2010. VEGF promotes malaria-associated acute lung injury in mice. PLoS Pathog. 6: e1000916.
40. Yoshimoto, T., Y. Takahama, C. R. Wang, T. Yoneto, S. Waki, and H. Nariuchi.1998. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J. Immunol. 160: 5500-5505. (Pubitemid 28267842)
41. Romero, J. F., G. H. Ibrahim, J. Renggli, H. Himmelrich, P. Graber, and G. Corradin. 2007. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations. Parasite Immunol. 29: 541-548. (Pubitemid 47609631)
42. Amante, F. H., A. Haque, A. C. Stanley, Fde. L. Rivera, L. M. Randall, Y. A. Wilson, G. Yeo, C. Pieper, B. S. Crabb, T. F. de Koning-Ward, et al. 2010. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J. Immunol. 185: 3632-3642.
43. Claser, C., B. Malleret, S. Y. Gun, A. Y. Wong, Z. W. Chang, P. Teo, P. C. See, S. W. Howland, F. Ginhoux, and L. Rénia. 2011. CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One 6: e18720.
44. Matusevicius, D., V. Navikas, M. Söderström, B. G. Xiao, M. Haglund, S. Fredrikson, and H. Link. 1996. Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells. J. Neuroimmunol. 66: 115-123. (Pubitemid 26193944)
45. Suen, W. E., C. M. Bergman, P. Hjelmström, and N. H. Ruddle. 1997. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186: 1233-1240. (Pubitemid 27469018)
46. Gommerman, J. L., K. Giza, S. Perper, I. Sizing, A. Ngam-Ek, C. Nickerson- Nutter, and J. L. Browning. 2003. A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. J. Clin. Invest. 112: 755-767. (Pubitemid 38057716)
47. Grau, G. E., L. F. Fajardo, P. F. Piguet, B. Allet, P. H. Lambert, and P. Vassalli. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237: 1210-1212. (Pubitemid 17124914)
48. Becher, B., B. G. Durell, and R. J. Noelle. 2002. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110: 493-497. (Pubitemid 34919703)
49. Kumaraguru, U., I. A. Davis, S. Deshpande, S. S. Tevethia, and B. T. Rouse. 2001. Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system. J. Immunol. 166: 1066-1074. (Pubitemid 32060264)
50. Gramaglia, I., D. N. Mauri, K. T. Miner, C. F. Ware, and M. Croft. 1999. Lymphotoxin alphabeta is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation. J. Immunol. 162: 1333-1338. (Pubitemid 29307003)
51. Jana, M., and K. Pahan. 2009. Induction of lymphotoxin-alpha by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70. Immunology 127: 312-325.